The UC Davis Cancer Center Mouse Biology (MB) shared resource is one of the original Cores initially established by the first CCSG submission. When first reviewed, the newly conceived and created MB shared resource received a rating score of """"""""outstanding"""""""" and several laudable comments from CCSG reviewers. Building upon that earlier success, and recognizing the essential importance of inducant mutations in the mouse genome to advances in research on the biology, diagnosis, treatment, and prevention of cancer in humans, the MB shared resource continues to be a critically integral component of the research mission of the Cancer Center. Utilizing the wide breadth and depth of expertise and infrastructure of the UC Davis Mouse Biology Program, this Core serves and supports cancer-related research by cancer center members utilizing genetically-altered mice. The Core provides all of the necessary technical elements for de novo creation and derivation of transgenic, knockout, and other types of induced mutant mice, husbandry, maintenance, health-care, and well-being of mice, and an extensive array of genotyping and phenotyping capabilities and services to Cancer Center members on a prioritized basis and at a subsidized cost. In addition. Core leadership faculty and their associates contribute intellectually to the development of research areas and projects by Cancer Center members who incorporate genetically altered mice into their research. Since its inception, the success of this Core to the overall mission of the Cancer Center is immediately evident by noting the accomplishments of the 32 Cancer Center members requesting more than 1300 Core services in support of their cancer-related research during the first 3 years of the CCSG. In this competitive renewal, the Core intends to continue to offer superior technical excellence and scientific input in anticipation ofan increasing number of requests from Cancer Center members during the next 5 years.
The specific aims of the MB shared resource are divided into 3 principal service categories: 1) Mouse Model Creation Services;2) Mouse Husbandry and Maintenance Services;and 3) Mouse Genotyping and Phenotyping Services .
Rodent models of cancer are a key tool in understand the development of tumors, and the efficacy of cancer treatments and cancer imaging substances. This resource makes such models available to researchers and therefore is very important to the conduct of cancer research, and ultimately to the development of more effective diagnostic and therapeutic strategies for the detection and cure of cancer.
|Zhang, Jin; Lucchesi, Christopher; Chen, Xinbin (2016) A new function for p53 tetramerization domain in cell fate control. Cell Cycle 15:2854-2855|
|Vinall, Ruth L; Tepper, Clifford G; Ripoll, Alexandra A Z et al. (2016) Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy. Genes Cancer 7:86-97|
|Kirschbaum, Mark H; Frankel, Paul; Synold, Timothy W et al. (2016) A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study. Leuk Lymphoma 57:2307-14|
|TachÃ©, VÃ©ronique; Bivina, Liga; White, Sophie et al. (2016) Lipoyltransferase 1 Gene Defect Resulting in Fatal Lactic Acidosis in Two Siblings. Case Rep Obstet Gynecol 2016:6520148|
|Lara, Joshua; Brunson, Ann; Keegan, Theresa H M et al. (2016) Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry. J Urol 196:1378-1382|
|Faisal, Farzana A; Sundi, Debasish; Tosoian, Jeffrey J et al. (2016) Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location. Eur Urol 70:14-7|
|Dang, Julie H T; Chen Jr, Moon S (2016) Increasing Hepatitis B Testing and Linkage to Care of Foreign-Born Asians, Sacramento, California, 2012-2013. Public Health Rep 131 Suppl 2:119-24|
|Rowson-Hodel, Ashley R; Berg, Anastasia L; Wald, Jessica H et al. (2016) Hexamethylene amiloride engages a novel reactive oxygen species- and lysosome-dependent programmed necrotic mechanism to selectively target breast cancer cells. Cancer Lett 375:62-72|
|Zhao, Yong; Tu, Mei-Juan; Wang, Wei-Peng et al. (2016) Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest. Sci Rep 6:26611|
|Monjazeb, Arta M; Kent, Michael S; Grossenbacher, Steven K et al. (2016) Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. Clin Cancer Res 22:4328-40|
Showing the most recent 10 out of 608 publications